Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/2/2026

Oral Sodium Chloride Therapy for Chronic Hyponatremia (Serum Na⁺ ≈ 130 mmol/L)

1. Indications & Initial Management

In patients with chronic hyponatremia (≥48 h) and mild symptoms who have not responded to fluid restriction, the American Association of Neurological Surgeons (AANS) recommends oral sodium chloride 1–3 g three times daily (total 3–9 g/day) together with continued fluid restriction of 1–1.5 L/day and close serum‑sodium monitoring every 4–24 h according to symptom severity. 1, 2

2. Assessment Prior to Therapy

2.1 Volume‑Status Evaluation

Determine whether hyponatremia is hypervolemic (e.g., cirrhosis, heart failure), euvolemic (SIADH), or hypovolemic (cerebral salt wasting) before selecting therapy. 3, 1

2.2 Symptom Severity

Classify symptoms as mild (nausea, headache) or severe (seizures, altered mental status) to guide monitoring frequency and correction targets. 1, 2

2.3 Chronicity

Chronic hyponatremia (>48 h) mandates slower correction to avoid osmotic demyelination syndrome (ODS). 1, 4

3. Dosing Protocols

3.1 Standard Oral Sodium Chloride Regimen

Start with 1 g (≈17 mEq Na⁺) of oral NaCl three times daily; titrate up to 3 g three times daily based on serum‑sodium response. 1, 2

3.2 Mild‑Symptom Dosing (Na⁺ ≈ 130 mmol/L)

Initial dose of 1–2 g orally three times daily, combined with fluid restriction of 1–1.5 L/day; check serum sodium every 4–6 h during the first 24 h. 1, 5, 6, 7

3.3 Condition‑Specific Adjustments

  • SIADH (euvolemic) – add ≈6 g (100 mEq) oral NaCl three times daily to 1 L/day fluid restriction and encourage a high‑protein diet.* 1, 2
  • Cerebral Salt Wasting (hypovolemic) – oral NaCl 1–3 g three times daily plus isotonic IV saline; consider fludrocortisone 0.1–0.3 mg daily for 7 days; do not fluid‑restrict.* 3, 1
  • Cirrhosis with ascites (hypervolemic) – discontinue or reduce diuretics, restrict fluids to 1–1.5 L/day, give albumin infusion as plasma expander; oral NaCl tablets are not recommended.* 8, 9, 10, 5, 6, 11

4. Safety Limits for Sodium Correction

Do not exceed an increase of 8 mmol/L in serum sodium over any 24‑hour period for chronic hyponatremia. 1, 4

In patients with cirrhosis or high ODS risk, limit correction to 4–6 mmol/L per 24 h, never surpassing the 8 mmol/L ceiling. 4, 7

For acute hyponatremia with mild symptoms, a correction of up to 6 mmol/L within 6 h is acceptable; chronic cases require slower rates. 1, 2

5. Monitoring Strategy

5.1 Frequency of Serum Sodium Checks

  • Mild symptoms – every 4–6 h.
  • Asymptomatic – once daily.
  • Severe symptoms – every 2 h.

All recommendations are from the AANS. 1, 2

5.2 Additional Parameters

  • Daily weight and intake/output charting.
  • Urine sodium and osmolality to confirm etiology.
  • Serum osmolality to exclude pseudohyponatremia.
  • Serum potassium – correct hypokalemia as it worsens hyponatremia.

These monitoring items are endorsed by the AANS. 1, 2, 3, 7

6. Alternative Dosing Approaches

Hourly oral NaCl dosing (≈1.2 g per hour for a 70‑kg adult) can mimic the effect of IV 3 % saline, requiring serum‑sodium checks every 2–4 h and immediate availability of D5W to reverse any over‑correction. 4

7. Common Pitfalls & Contraindications

  • Do not use oral sodium tablets in hypervolemic hyponatremia (e.g., cirrhosis, heart failure) because they exacerbate volume overload; manage with fluid restriction and diuretic adjustment per the American Gastroenterological Association (AGA) guidelines.* 10, 11, 5, 6

  • Over‑correction beyond 8 mmol/L in 24 h markedly increases the risk of ODS; adhere to the correction limits above.* 1, 4

  • Ensure adequate dietary protein and overall solute intake to maximize the efficacy of oral sodium supplementation.* 1

8. Escalation When Oral Sodium Fails

If serum sodium has not risen after 24–48 h of oral NaCl therapy: